Arron, orcid.org/0000-0002-6427-1278
Personalized Treatment with PlexusDx Precision Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
NICE guidance recommends initial treatment with hydroxocobalamin 1mg intramuscularly three times weekly for two weeks, followed by maintenance therapy
Activity modification during treatment is essential for optimal results
Over time, consistent use of NMT can improve nerve function, potentially slowing the progression of neuropathy and preventing further complications
500-1,000 mg per session in higher-dose clinic protocols